Current Studies
Children’s Meningococcal B vaccine study for 10-12 year olds
Background:
This study is being done to look at a new vaccine that might prevent meningococcal disease. Meningococcal disease is a disease that causes the tissues that surround the brain and spinal cord to become swollen and inflamed. Meningococcal type B disease is caused by a germ called meningococcal Type B. The likelihood of experiencing meningococcal B disease for any individual is very low. Adolescents / teens have somewhat of an increased chance of getting the disease compared to the general population.
Background:
This study is being done to look at a new vaccine that might prevent meningococcal disease. Meningococcal disease is a disease that causes the tissues that surround the brain and spinal cord to become swollen and inflamed. Meningococcal type B disease is caused by a germ called meningococcal Type B. The likelihood of experiencing meningococcal B disease for any individual is very low. Adolescents / teens have somewhat of an increased chance of getting the disease compared to the general population.
Purpose of the Study:
The purpose of this study is to learn what the effects are of the research vaccine, when taking it with two other vaccines at the same time. The two additional vaccines are FDA approved and are typically given as part of the routine vaccination schedule for adolescents. One is Menactra® (MCV4) and is approved for the prevention of 4 types of meningitis (Meningococcal Groups A, C, Y, and W-135) but not meningococcus B. The second vaccine is Adacel® (Tdap) and is approved to prevent tetanus, diphtheria, and pertussis (whooping cough).
Important points regarding the study:
- Your child may be eligible to participate if he/she is healthy and 10-12 years of age.
- The study will involve 6 visits and 1 phone call over about 14 months.
- You will be paid $85 for each visit.
To learn more:
Please refer to Study # 287.
410-6333 (toll free)